Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6823660 | Schizophrenia Research | 2015 | 10 Pages |
Abstract
CR's effect sizes in early illness were smaller than those in chronic schizophrenia, perhaps because of participants' reduced scope for improvement, though trials' small number and size produces uncertain estimates of effect. However, significant benefits were seen in functioning and symptoms and moderator analyses indicate factors that may increase CR's effect. Findings here, theoretical considerations and trials in chronic schizophrenia suggest that targeting social cognition might also enhance its efficacy.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Emily R. Revell, Jo C. Neill, Michael Harte, Zarshed Khan, Richard J. Drake,